A Phase III Randomized Double-Blind, Placebo-Controlled

Project: Research project

Project Details

Description

A Phase III Randomized Double-Blind, Placebo-Controlled Study Examining the Efficacy and Safety of ALTU-135 Treatment in Patients with Cystic Fibrosis-Related Exocrine
StatusFinished
Effective start/end date5/2/0710/30/08

Funding

  • Altus Pharmaceuticals Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.